Cargando…
Dasatinib-Related Chylothorax
Dasatinib is a potent second-generation tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The most common adverse event associated with dasatinib therapy is fluid retention, including pleural effusion. Dasatinib-related chylothorax has rarely been reported. The clinical manife...
Autores principales: | Huang, Yen-Min, Wang, Cheng-Hsu, Huang, Jen-Seng, Yeh, Kun-Yun, Lai, Chien-Hong, Wu, Tsung-Han, Chang, Pei-Hung, Chang, Yueh-Shih, Lan, Yii-Jenq |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439910/ https://www.ncbi.nlm.nih.gov/pubmed/25805678 http://dx.doi.org/10.4274/tjh.2012.0196 |
Ejemplares similares
-
DASATINIB-RELATED CHYLOTHORAX
por: Young, Katherine, et al.
Publicado: (2019) -
A Dasatinib-Induced Chylothorax Persisting After the Discontinuation of Dasatinib
por: Bradt, Nicolas, et al.
Publicado: (2022) -
Dasatinib-induced pleural effusion: Chylothorax, an option to consider
por: Ferreiro, Lucía, et al.
Publicado: (2016) -
Dasatinib: Chylothorax and right pleural effusion: case report
Publicado: (2019) -
Dasatinib-Induced Chylothorax: A Clinical Laboratory’s Perspective
por: Martínez, Rafael J. García, et al.
Publicado: (2023)